Liquid purification or separation – Flow – fluid pressure or material level – responsive
Patent
1995-04-06
1997-11-25
Kim, John
Liquid purification or separation
Flow, fluid pressure or material level, responsive
210 85, 210109, 210143, 210252, 2102571, 210258, 2104161, 210418, 604 65, 604 67, B01D 3600, A61M 136
Patent
active
056908156
DESCRIPTION:
BRIEF SUMMARY
TECHNICAL FIELD
This invention relates to a system for automatically processing biological fluid and, particularly, to improved methods and apparatuses for preparing, from donated biological fluid such as whole blood, packed red cells (hereinafter PRC), a platelet suspension, usually concentrated as platelet concentrate (hereinafter PC), and plasma.
BACKGROUND OF THE INVENTION
Donated whole blood may be separated into its various components and analogous products, thereby making these different blood products available as a transfusion product. For example, a plastic collection bag containing whole blood may be centrifuged to form (1) a supernatant layer of platelet-rich plasma (PRP) and a sediment layer of packed red cells (PRC) with a buffy coat (BC) therebetween or (2) a supernatant layer of platelet-poor plasma (PPP), a sediment layer of PRC, and an intermediate layer such as buffy coat (BC). A bag containing PRP may be centrifuged to form a supernatant layer of plasma and a sediment platelet-containing layer that may be processed to form platelet concentrate (PC). Similarly, a bag containing buffy coat may be centrifuged to form a supernatant layer including platelets and a sediment layer including red cells and the supernatant layer may be separated and processed to form PC.
The separation of whole blood into components as described above may also produce leukocyte contaminated components. It is desirable to reduce the leukocyte concentration of each of the blood components by at least 70%, since the presence of leukocytes may adversely affect the storage life of the components, and/or cause undesirable effects when they are transfused into a patient. Accordingly, blood components may be leukocyte depleted, preferably by passing them through a porous medium such as a leukocyte depletion medium.
Additionally, processing of blood to provide blood components, particularly to provide leukocyte depleted blood products, may lead to the presence of gas or air, in particular oxygen, in the blood components or in the container holding the blood components, e.g., a storage container such as a satellite bag. This may lead to an impairment of the quality of the blood components and may decrease their storage life. Furthermore, the presence of air or gas in the satellite bag may present a risk factor to a patient's being transfused with a blood component.
For this reason, the separation of blood into components has substantial therapeutic and monetary value, placing additional pressure on blood banks to increase component yield and reduce costs per unit of processed biological fluid.
In view of this, there is a growing need for an efficient system and method for separating a biological fluid (e.g., whole blood) into its components. Blood bank personnel have by attempting to increase the yields of blood components in a variety of ways. However, any saving resulting from increasing the yield may be offset by the increased labor cost, if the operator of the processing system must continuously and carefully monitor the system to increase the yield.
However, increasing the yield may be counterproductive. For example, expressing more supernatant PRP from the collection container to increase the yield of platelets in the satellite container may result in the passage of red cells into the satellite container. Since red cells are undesirable, the supernatant fluid must be discarded or recentrifuged so that the red cells may be separated from the platelets.
Accordingly, the previously described methods reflect a generally unsatisfying compromise between the pressing need to maximize the yield of the historically valuable blood components such as PC, plasma, and red cells from whole blood samples, and provide for leukocyte depletion, while minimizing the effort and expense involved.
Because of the high cost and limited availability of blood components, a device comprising a porous medium used to deplete leukocytes from biological fluid should deliver the highest possible proportion of the component present in the donate
REFERENCES:
patent: Re33924 (1992-05-01), Valeri
patent: 38158 (1863-04-01), Ferris
patent: 2579092 (1951-12-01), Rockwell
patent: 2757375 (1956-07-01), Rieutord et al.
patent: 3000540 (1961-09-01), Wheeler
patent: 3030082 (1962-04-01), Matzen
patent: 3032037 (1962-05-01), Huber
patent: 3577579 (1971-05-01), Duve et al.
patent: 3802432 (1974-04-01), Djerassi
patent: 3869924 (1975-03-01), Beezer
patent: 3892236 (1975-07-01), Djerassi
patent: 4016077 (1977-04-01), Schreiber
patent: 4021353 (1977-05-01), Raines et al.
patent: 4169681 (1979-10-01), Kato
patent: 4303193 (1981-12-01), Latham, Jr.
patent: 4316576 (1982-02-01), Cullis et al.
patent: 4322298 (1982-03-01), Persidsky
patent: 4350585 (1982-09-01), Johansson et al.
patent: 4479760 (1984-10-01), Bilstad et al.
patent: 4479761 (1984-10-01), Bilstad et al.
patent: 4507119 (1985-03-01), Spencer
patent: 4588407 (1986-05-01), Isono et al.
patent: 4601213 (1986-07-01), Kimball
patent: 4608178 (1986-08-01), Johansson et al.
patent: 4657542 (1987-04-01), Ohachi
patent: 4663032 (1987-05-01), Loos et al.
patent: 4680025 (1987-07-01), Kruger et al.
patent: 4708938 (1987-11-01), Hickinbotham
patent: 4786286 (1988-11-01), Cerny et al.
patent: 4795314 (1989-01-01), Prybella et al.
patent: 4807676 (1989-02-01), Cerny et al.
patent: 4810378 (1989-03-01), Carmen et al.
patent: 4828716 (1989-05-01), McEwen et al.
patent: 4834890 (1989-05-01), Brown et al.
patent: 4838861 (1989-06-01), Sharp
patent: 4842576 (1989-06-01), Lysaght et al.
patent: 4880548 (1989-11-01), Pall et al.
patent: 4898573 (1990-02-01), Takenaka et al.
patent: 4923620 (1990-05-01), Pall
patent: 4925572 (1990-05-01), Pall
patent: 4943287 (1990-07-01), Carmen
patent: 4955860 (1990-09-01), Ruano
patent: 4957637 (1990-09-01), Cornell
patent: 4976694 (1990-12-01), Schreibman
patent: 4976851 (1990-12-01), Tanokura et al.
patent: 4985153 (1991-01-01), Kuroda et al.
patent: 5008012 (1991-04-01), Hagihara et al.
patent: 5032288 (1991-07-01), Columbus et al.
patent: 5035865 (1991-07-01), Inaba et al.
patent: 5045185 (1991-09-01), Ohnaka et al.
patent: 5057429 (1991-10-01), Watanabe et al.
patent: 5061451 (1991-10-01), Ganshirt et al.
patent: 5074839 (1991-12-01), Choksi et al.
patent: 5085345 (1992-02-01), Wells
patent: 5089146 (1992-02-01), Carmen et al.
patent: 5092996 (1992-03-01), Spielberg
patent: 5098372 (1992-03-01), Jonsson
patent: 5100564 (1992-03-01), Pall et al.
patent: 5102407 (1992-04-01), Carmen et al.
patent: 5124030 (1992-06-01), Tanokura et al.
patent: 5126054 (1992-06-01), Matkovich
patent: 5135646 (1992-08-01), Tanokura et al.
patent: 5139685 (1992-08-01), De Castro et al.
patent: 5141490 (1992-08-01), Fujii et al.
patent: 5147330 (1992-09-01), Kogel
patent: 5152905 (1992-10-01), Pall et al.
patent: 5154716 (1992-10-01), Bauman et al.
patent: 5171456 (1992-12-01), Hwang et al.
patent: 5174894 (1992-12-01), Ohsawa et al.
patent: 5178603 (1993-01-01), Prince
patent: 5180504 (1993-01-01), Johnson et al.
patent: 5207645 (1993-05-01), Ross et al.
patent: 5217627 (1993-06-01), Pall et al.
patent: 5221474 (1993-06-01), Yokono et al.
patent: 5229012 (1993-07-01), Pall et al.
patent: 5234403 (1993-08-01), Yoda et al.
patent: 5234608 (1993-08-01), Duff
patent: 5242382 (1993-09-01), Gorsuch et al.
patent: 5242384 (1993-09-01), Robinson et al.
patent: 5254248 (1993-10-01), Nakamura
patent: 5256279 (1993-10-01), Voznick et al.
patent: 5258126 (1993-11-01), Pall et al.
patent: 5282982 (1994-02-01), Wells
patent: 5322620 (1994-06-01), Brown et al.
patent: 5411482 (1995-05-01), Campbell
patent: 5433704 (1995-07-01), Ross et al.
patent: 5451321 (1995-09-01), Matkovich
patent: 5547108 (1996-08-01), Gsell et al.
Bormann Thomas J.
Gsell Thomas C.
Krasnoff Eric J.
Matkovich Vlado I.
Pascale Frank R.
Kim John
Pall Corporation
LandOfFree
Automated system for processing biological fluid does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Automated system for processing biological fluid, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Automated system for processing biological fluid will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2103679